Does the PCSK9 rs11591147 T allele lower LDL cholesterol?

The PCSK9 rs11591147 polymorphism is a significant genetic determinant of low-density lipoprotein cholesterol (LDL-C) levels, representing a natural "loss-of-function" mutation that mirrors the effects of modern pharmaceutical PCSK9 inhibitors.

Clinical and effectiveness evidence

The rs11591147 T allele (encoding the R46L substitution) is robustly associated with reduced LDL-C across multiple large-scale genetic studies and meta-analyses.

• LDL-C reduction: Carriers of the T allele (GT or TT genotypes) typically exhibit LDL-C levels that are 17–20 mg/dL (0.44–0.5 mmol/L) lower than those with the GG genotype.
• Cardiovascular protection: This genetic reduction in cholesterol translates into a significant clinical benefit, with T-allele carriers showing an approximate 23% reduction in the risk of coronary heart disease.
• Genotype interpretation: The GG genotype represents the "wild-type" or reference state. Individuals with the GG genotype lack this specific protective mutation and consequently have higher baseline LDL-C levels compared to T-allele carriers.

Mechanistic explanations

The association between the T allele and lower cholesterol is driven by the role of the PCSK9 protein in regulating the hepatic LDL receptor (LDLR).

• Normal function (GG genotype): PCSK9 binds to LDLRs on the surface of liver cells and escorts them to lysosomes for degradation. This reduces the number of available receptors to clear LDL from the bloodstream.
• Loss of function (T allele): The T allele causes a leucine substitution at position 46 (R46L), which impairs the protein's structural stability, folding, and secretion. This mutation significantly reduces the binding affinity of PCSK9 for the LDLR.
• Resulting effect: Because the mutated PCSK9 protein cannot efficiently degrade the LDLR, the density of these receptors on the hepatocyte surface increases. This leads to enhanced clearance of circulating LDL particles, lowering plasma cholesterol levels naturally.

Bottom line

The rs11591147 T allele is a well-validated genetic marker for lower LDL cholesterol and reduced cardiovascular risk, while the GG genotype confirms the absence of this protective variant and a higher baseline LDL-C profile.